Within the tumor microenvironment, MMP-9 activation of the nanovesicle surface peptides increased their uptake, and they subsequently released siRNAs and chemotherapeutic drugs to effectively inhibit non-small cell lung cancer growth [150]. The gene discussed is MMP9; the disease is neoplasm.